PURPOSE: [(18)F]-FEPPA is a translocator protein (18 kDa, TSPO) positron emission tomography (PET) radiotracer. Radiation dosimetry was estimated from the whole body biodistribution, taking into consideration TSPO rs6971 (Ala147Thr) polymorphism. PROCEDURES: [(18)F]-FEPPA whole body PET scans were acquired for six healthy subjects. Time-activity curves were generated from regions of interest of nine organs, from which normalized accumulated activities were calculated and thus internal dose, using OLINDA/EXM 1.1. Genotyping of rs6971, associated with high- and low-affinity [(18)F]-FEPPA binding (high-affinity binder (HAB) and low-affinity binder (LAB)), was performed. RESULTS: Five subjects exhibited the C/C (HAB) allele, and the other carried the minor allele T/T (LAB). The LAB whole body biodistribution showed highest radioactivity accumulation in bladder, whereas in HABs, the spleen received the highest dose. The effective dose of the single LAB (16.3 μSv/MBq) was 23 % less than the mean of the HABs (21.0 ± 2.9 μSv/MBq). When including all subjects, the effective dose was 20.2 ± 3.0 μSv/MBq. CONCLUSIONS: [(18)F]-FEPPA radiation dose is consistent with other (18)F-labeled radioligands and the Ala147Thr genotype agreed with [(18)F]-FEPPA distribution.
PURPOSE: [(18)F]-FEPPA is a translocator protein (18 kDa, TSPO) positron emission tomography (PET) radiotracer. Radiation dosimetry was estimated from the whole body biodistribution, taking into consideration TSPO rs6971 (Ala147Thr) polymorphism. PROCEDURES: [(18)F]-FEPPA whole body PET scans were acquired for six healthy subjects. Time-activity curves were generated from regions of interest of nine organs, from which normalized accumulated activities were calculated and thus internal dose, using OLINDA/EXM 1.1. Genotyping of rs6971, associated with high- and low-affinity [(18)F]-FEPPA binding (high-affinity binder (HAB) and low-affinity binder (LAB)), was performed. RESULTS: Five subjects exhibited the C/C (HAB) allele, and the other carried the minor allele T/T (LAB). The LAB whole body biodistribution showed highest radioactivity accumulation in bladder, whereas in HABs, the spleen received the highest dose. The effective dose of the single LAB (16.3 μSv/MBq) was 23 % less than the mean of the HABs (21.0 ± 2.9 μSv/MBq). When including all subjects, the effective dose was 20.2 ± 3.0 μSv/MBq. CONCLUSIONS: [(18)F]-FEPPA radiation dose is consistent with other (18)F-labeled radioligands and the Ala147Thr genotype agreed with [(18)F]-FEPPA distribution.
Authors: Marco Brambilla; Chiara Secco; Marco Dominietto; Roberta Matheoud; Gianmauro Sacchetti; Eugenio Inglese Journal: J Nucl Med Date: 2005-12 Impact factor: 10.057
Authors: A Gerhard; B Neumaier; E Elitok; G Glatting; V Ries; R Tomczak; A C Ludolph; S N Reske Journal: Neuroreport Date: 2000-09-11 Impact factor: 1.837
Authors: Yota Fujimura; Yasuyuki Kimura; Fabrice G Siméon; Leah P Dickstein; Victor W Pike; Robert B Innis; Masahiro Fujita Journal: J Nucl Med Date: 2009-12-15 Impact factor: 10.057
Authors: Jussi Hirvonen; Anne Roivainen; Jere Virta; Semi Helin; Kjell Någren; Juha O Rinne Journal: Eur J Nucl Med Mol Imaging Date: 2009-10-28 Impact factor: 9.236
Authors: F Bretin; M A Bahri; C Bernard; G Warnock; J Aerts; N Mestdagh; T Buchanan; C Otoul; F Koestler; F Mievis; F Giacomelli; C Degueldre; R Hustinx; A Luxen; A Seret; A Plenevaux; E Salmon Journal: Mol Imaging Biol Date: 2015-08 Impact factor: 3.488
Authors: Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy Journal: Front Med (Lausanne) Date: 2022-06-06
Authors: Karmen K Yoder; Kwangsik Nho; Shannon L Risacher; Sungeun Kim; Li Shen; Andrew J Saykin Journal: J Nucl Med Date: 2013-06-19 Impact factor: 10.057
Authors: S V Hartimath; S Khanapur; R Boominathan; L Jiang; P Cheng; F F Yong; P W Tan; E G Robins; J L Goggi Journal: Mol Metab Date: 2019-05-06 Impact factor: 7.422
Authors: Matthew Zammit; Yunlong Tao; Miles E Olsen; Jeanette Metzger; Scott C Vermilyea; Kathryn Bjornson; Maxim Slesarev; Walter F Block; Kerri Fuchs; Sean Phillips; Viktorya Bondarenko; Su-Chun Zhang; Marina E Emborg; Bradley T Christian Journal: EJNMMI Res Date: 2020-08-06 Impact factor: 3.138